MONC:MILMoncler SpA Analysis
Data as of 2026-03-13 - not real-time
€52.56
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Moncler shares have rallied after a strong earnings release, with the stock now trading at €52.56, just above its 50‑day SMA (€52.21) and comfortably over the 200‑day SMA (€51.87), indicating a short‑term bullish bias. The RSI sits at 45.5, suggesting neutral momentum, while the MACD histogram remains negative and volume is on a decreasing trend, adding a hint of caution. Volatility is elevated at roughly 47% over the past 30 days, but the computed beta of 0.27 points to low market‑beta risk.
Fundamentally, Moncler delivers premium margins (gross 78%, operating 36%) on €3.13 bn of revenue and generates a solid €2.31 trailing EPS with a 2.64% dividend yield supported by a 56% payout ratio. The DCF‑derived fair value of €38.3 suggests the stock is currently overvalued, yet analyst consensus targets of €61 imply a further ~16% upside, positioning the valuation as roughly fair and the growth/value profile as a blend. The dividend appears sustainable given strong cash balances and moderate leverage.
Fundamentally, Moncler delivers premium margins (gross 78%, operating 36%) on €3.13 bn of revenue and generates a solid €2.31 trailing EPS with a 2.64% dividend yield supported by a 56% payout ratio. The DCF‑derived fair value of €38.3 suggests the stock is currently overvalued, yet analyst consensus targets of €61 imply a further ~16% upside, positioning the valuation as roughly fair and the growth/value profile as a blend. The dividend appears sustainable given strong cash balances and moderate leverage.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- Decreasing trading volume
- Price near key support at €49.11
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong operating and profit margins
- Dividend yield of 2.64% with sustainable payout
- Analyst target price indicating ~16% upside
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Premium brand positioning and global footprint
- Consistent dividend policy
- Valuation gap to DCF fair value suggesting limited upside beyond analyst targets
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin20.01%
P/E Ratio22.8
ROE16.86%
ROA10.87%
Debt/Equity28.81
P/B Ratio4.2
Op. Cash Flow€990.7M
Technical Analysis
TrendBullish
RSI45.5
Support€49.11
Resistance€59.34
MA 20€54.52
MA 50€52.21
MA 200€51.87
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value€38.31
Target Price€61.13
Upside/Downside16.30%
GradeFair
TypeBlend
Dividend Yield2.64%
Risk Assessment
Beta0.27
Volatility47.40%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.